Zacks Investment Research
03 Jun 2026, 15:46 UTC · 2h ago
Medtronic Q4 Earnings and Revenues Beat, Stock Rises in Pre-Market
Search tags
Zacks Investment Research
03 Jun 2026, 15:46 UTC · 2h ago
Search tags
Story key points
4 claims · impact-rated
Medtronic's fourth-quarter fiscal 2026 adjusted earnings of $1.55 per share beat the Zacks Consensus Estimate by 0.58%. — An earnings beat typically signals operational strength and provides immediate positive momentum for the stock price.
+0.40Medtronic's fourth-quarter revenue rose 9.9% year-over-year to $9.81 billion, beating consensus estimates by 1.48%. — Strong top-line growth and a beat suggest robust demand for products, particularly in the cardiac ablation segment.
+0.30Medtronic's full-year fiscal 2026 adjusted EPS of $5.53 missed the Zacks Consensus Estimate by 0.2%. — A miss on the annual bottom line can act as a drag on valuation despite quarterly beats.
-0.20Continue reading
6 related stories
Medtronic's Cardiac Ablation Solutions revenues grew 78% globally, with 124% growth in the United States. — High growth in a specific high-value franchise indicates a competitive advantage and a strong future growth lever.
Ticker attribution
Model heads
The company beat quarterly earnings and revenue estimates, saw strong growth in cardiac ablation, and experienced a pre-market share price increase.
No ticker relationship head found.
Early access
News Impact Screener scores every headline against the stocks it moves — before the chart reacts. Join the early-access list and get alerted the moment a story hits your tickers.
Impact vectors
2 dimensions · 9 clusters
Market reaction
10 bid · 0 offered
No stock impact ranking available yet.
Zacks Investment Research
2h ago
